The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort

Kidney International

Volumn 71, Issue 7, 2007, Pages 693-700

  Kitiyakara, C ^a   Yamwong, S ^a   Cheepudomwit, S ^a   Domrongkitchaiporn, S ^a   Unkurapinun, N ^b   Pakpeankitvatana, V ^c   Sritara, P ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Electricity Generating Authority of Thailand   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

IDF; NCEP; Obesity; Renal failure; Thai; Waist circumference

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SOUTHEAST ASIA;

ADULT; ASIA, SOUTHEASTERN; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; PREVALENCE; PROSPECTIVE STUDIES;

EID: 33947656524     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002128     Document Type: Article

References (30)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
2. Tan CE, Ma S, Wai D et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186.
3. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/MetSyndrome_FINAL. pdf.
4. Genuth S, Alberti KG, Bennett P. et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
5. Kosulwat V. The nutrition and health transition in Thailand. Public Health Nutr 2002; 5: 183-189.
6. Gu D, Reynolds K, Wu X et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
7. Bagby SP. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? J Am Soc Nephrol 2004; 15: 2775-2791.
8. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
9. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
10. Tanaka H, Shiohira Y, Uezu Y et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374.
11. Ko GT, Cockram CS, Chow CC et al. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract 2006; 73: 58-64.
12. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.. Diabetes Care 2005; 28: 2745-2749.
13. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia: Melbourne. ISBN 0-9577082-1-1, 2000.
14. Whelton PK, Perneger TV, He J et al. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. J Hum Hypertens 1996; 10: 683-689.
15. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 213-219.
16. Mandavilli A, Cyranoski D. Asias big problem. Nat Med 2004; 10: 325-327.
17. Chittinandana A. 2000 Thailand renal replacement therapy registry (TRT Registry) report. JNST 2001; 7: 32-33.
18. Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908-1919.
19. Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000; 58: 293-301.
20. Verani RR. Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 1992; 20: 629-634.
21. Iseki K, Ikemiya Y, Fukiyama K. Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl 1997; 63: S169-S170.
22. Kopple JD, Greene T, Chumlea WC et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 2000; 57: 1688-1703.
23. Domrongkitchaiporn S, Sritara P, Kitiyakara C et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005; 16: 791-799.
24. Sritara P, Cheepudomwit S, Chapman N et al. Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand Study. Int J Epidemiol 2003; 32: 461-468.
25. Burnstein M, Scholnick HR, Morfin R. Determination of HDL-cholesterol. J Lipid Res 1970; 11: 583-587.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
27. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
28. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
29. Jones CA, McQuillan GM, Kusek JW et al. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998; 32: 992-999.
30. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. National Cholesterol Education Program. National Heart, Lung, and Blood Institute National Institutes of Health NIH: Bethesda, MD. Publication No. 02-5215, 2002.